Literature DB >> 17048035

FDG-PET/CT can visualise the extent of inflammation in rheumatoid arthritis of the tarsus.

Wouter V Vogel1, Piet L C M van Riel, Wim J G Oyen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17048035     DOI： 10.1007/s00259-006-0246-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  2 in total

1.  Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET.

Authors:  Catherine Beckers; Clio Ribbens; Béatrice André; Stefaan Marcelis; Olivier Kaye; Luc Mathy; Marie-Joëlle Kaiser; Roland Hustinx; Jacqueline Foidart; Michel G Malaise
Journal:  J Nucl Med       Date:  2004-06       Impact factor: 10.057

2.  Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis.

Authors:  R P Polisson; O I Schoenberg; A Fischman; R Rubin; L S Simon; D Rosenthal; W E Palmer
Journal:  Arthritis Rheum       Date:  1995-06
  2 in total
  8 in total

Review 1.  Evolving role of FDG PET imaging in assessing joint disorders: a systematic review.

Authors:  Kathleen Carey; Babak Saboury; Sandip Basu; Alex Brothers; Alexis Ogdie; Tom Werner; Drew A Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-14       Impact factor: 9.236

2.  Current imaging strategies in rheumatoid arthritis.

Authors:  Merissa N Zeman; Peter Jh Scott
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

Review 3.  Rheumatoid arthritis: Nuclear Medicine state-of-the-art imaging.

Authors:  Paulo Henrique Rosado-de-Castro; Sergio Augusto Lopes de Souza; Dângelo Alexandre; Lea Mirian Barbosa da Fonseca; Bianca Gutfilen
Journal:  World J Orthop       Date:  2014-07-18

4.  Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis.

Authors:  Patricia G Oliveira; Ricard Garcia-Carbonell; Adam P Croft; Marta F Bustamante; Jeff M Smith; Ramon L Serrano; Elsa Sanchez-Lopez; Xiao Liu; Tatiana Kisseleva; Nissim Hay; Christopher D Buckley; Gary S Firestein; Anne N Murphy; Shigeki Miyamoto; Monica Guma
Journal:  Ann Rheum Dis       Date:  2018-07-30       Impact factor: 19.103

5.  Protective effect of taraxasterol against rheumatoid arthritis by the modulation of inflammatory responses in mice.

Authors:  Shu-Hua Jiang; Li-Feng Ping; Feng-Yan Sun; Xiao-Lei Wang; Zhi-Juan Sun
Journal:  Exp Ther Med       Date:  2016-11-02       Impact factor: 2.447

Review 6.  Emerging optical and nuclear medicine imaging methods in rheumatoid arthritis.

Authors:  James M Mountz; Abass Alavi; John D Mountz
Journal:  Nat Rev Rheumatol       Date:  2012-09-25       Impact factor: 20.543

7.  In vivo molecular imaging of experimental joint inflammation by combined (18)F-FDG positron emission tomography and computed tomography.

Authors:  Ingo M Irmler; Thomas Opfermann; Peter Gebhardt; Mieczyslaw Gajda; Rolf Bräuer; Hans P Saluz; Thomas Kamradt
Journal:  Arthritis Res Ther       Date:  2010-11-03       Impact factor: 5.156

8.  Quantifying disease activity in rheumatoid arthritis with the TSPO PET ligand 18F-GE-180 and comparison with 18F-FDG and DCE-MRI.

Authors:  Marius de Groot; Neel Patel; Roido Manavaki; Robert L Janiczek; Mats Bergstrom; Andrew Östör; Danielle Gerlag; Alexandra Roberts; Martin J Graves; Yakshitha Karkera; Disala Fernando; Prafull Mistry; Adam Walker; Nicolas Wisniacki; Tim D Fryer; Pilar Jimenez-Royo
Journal:  EJNMMI Res       Date:  2019-12-19       Impact factor: 3.138
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.